Hospital
Henry Ford Health System
Henry Ford Health System was paid $19.27M by Medicaid between Jan 2018 and Dec 2024, across 252 billing codes. Its largest line is 99285, emergency room visit (most serious) — 29% of everything it billed.
33Billing provider infoHENRY FORD HEALTH SYSTEM
WEST BLOOMFIELD, MI 48322
WEST BLOOMFIELD, MI 48322
33aNPI1407867559assigned 08/11/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$19.27M
24GClaims511,634
24DCodes billed252
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Michigan
Rank by total paid#48 of 86
Median peer was paid$21.55M
This provider vs. median0.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DAMSCHRODER, ROBIN controls 14+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 68,292 | $2.44M | |
| 2019 | 67,160 | $2.32M | |
| 2020 | 66,014 | $2.40M | |
| 2021 | 87,927 | $3.14M | |
| 2022 | 90,324 | $3.30M | |
| 2023 | 74,865 | $3.06M | |
| 2024incomplete | 57,052 | $2.62M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 29% | 17,811 | 16,709 | $5.63M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 16% | 51,260 | 44,064 | $3.13M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 9.0% | 9,945 | 9,465 | $1.73M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.7% | 9,476 | 9,169 | $1.10M |
| G0378 | Hospital observation service, per hour | 5.3% | 3,564 | 3,249 | $1.03M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.7% | 9,796 | 9,238 | $907K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.8% | 10,146 | 8,511 | $537K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.2% | 3,579 | 3,512 | $421K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.7% | 3,143 | 3,086 | $322K |
| 59025 | Fetal non-stress test | 1.7% | 3,845 | 1,762 | $320K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.3% | 3,683 | 3,623 | $259K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 1.3% | 1,078 | 1,062 | $241K |
240 more codes
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 1.2% | 79 | $238K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.0% | 2,541 | $194K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 5,346 | $182K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 2,157 | $175K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 3,839 | $159K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 7,003 | $158K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 2,188 | $156K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,507 | $136K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 2,409 | $119K |
| 76830 | Ultrasound, transvaginal | <1% | 2,036 | $116K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 2,165 | $110K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 775 | $94K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,709 | $91K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 759 | $90K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 254 | $81K |
| 76801 | <1% | 1,238 | $71K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 1,701 | $68K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,748 | $63K |
| 86900 | <1% | 5,341 | $61K | |
| 80061 | Lipid panel | <1% | 2,374 | $51K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 4,682 | $47K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 4,645 | $46K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 690 | $39K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 2,205 | $39K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 621 | $38K |
| Q3014 | Telehealth originating site facility fee | <1% | 2,317 | $37K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 500 | $37K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 190 | $36K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,316 | $33K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,784 | $31K |
| 93975 | <1% | 297 | $31K | |
| 76642 | <1% | 787 | $28K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 431 | $28K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 311 | $28K |
| 97161 | <1% | 661 | $28K | |
| 80053 | Comprehensive metabolic panel | <1% | 12,834 | $27K |
| 70496 | <1% | 221 | $27K | |
| 20610 | <1% | 181 | $23K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 434 | $23K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,702 | $22K |
| 86780 | <1% | 2,537 | $22K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 164 | $20K |
| 93971 | <1% | 401 | $20K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 231 | $20K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 17,818 | $19K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 649 | $19K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 4,317 | $17K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,809 | $17K |
| 77065 | Tomosynthesis, mammo | <1% | 393 | $16K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 1,800 | $16K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 25,048 | $16K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 800 | $14K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,229 | $12K |
| 76881 | <1% | 207 | $12K | |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | <1% | 50 | $12K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 3,072 | $11K |
| 76882 | <1% | 262 | $11K | |
| 74183 | <1% | 25 | $11K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 748 | $11K |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 908 | $11K |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | <1% | 869 | $11K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 377 | $10K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 734 | $10K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,924 | $9K |
| 72141 | <1% | 69 | $9K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 139 | $8K |
| 84702 | <1% | 5,635 | $8K | |
| 95700 | <1% | 61 | $8K | |
| 77066 | Tomosynthesis, mammo | <1% | 120 | $7K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 11,150 | $7K |
| 85027 | <1% | 8,750 | $6K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 696 | $6K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 492 | $6K |
| 95713 | <1% | 24 | $6K | |
| 51798 | <1% | 1,905 | $6K | |
| 87808 | <1% | 3,189 | $6K | |
| 76536 | <1% | 103 | $5K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,167 | $5K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,727 | $5K |
| 83735 | <1% | 13,873 | $5K | |
| 31231 | <1% | 53 | $5K | |
| 82728 | <1% | 1,222 | $4K | |
| 85610 | <1% | 10,349 | $4K | |
| 83880 | <1% | 2,523 | $4K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 65 | $4K |
| 82607 | <1% | 1,154 | $4K | |
| 72197 | <1% | 13 | $4K | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 388 | $4K |
| 92557 | <1% | 669 | $4K | |
| 72100 | <1% | 514 | $4K | |
| 84439 | <1% | 1,013 | $3K | |
| 82962 | <1% | 6,080 | $3K | |
| 29580 | <1% | 43 | $3K | |
| 73610 | <1% | 1,016 | $3K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 160 | $3K |
| 73562 | <1% | 1,213 | $3K | |
| 72131 | <1% | 68 | $3K | |
| 82947 | <1% | 1,187 | $3K | |
| 93017 | <1% | 128 | $3K | |
| 83550 | <1% | 891 | $3K | |
| 71250 | <1% | 63 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,533 | $2K |
| 73630 | <1% | 1,001 | $2K | |
| 76770 | <1% | 40 | $2K | |
| 82248 | <1% | 7,346 | $2K | |
| 83540 | <1% | 998 | $2K | |
| 80074 | <1% | 182 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 838 | $2K |
| G0008 | Administration of influenza virus vaccine | <1% | 253 | $2K |
| 82746 | <1% | 634 | $2K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 3,064 | $2K |
| 87340 | <1% | 1,619 | $2K | |
| 73030 | <1% | 816 | $2K | |
| 92550 | <1% | 107 | $2K | |
| 93970 | <1% | 25 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,444 | $2K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 15 | $2K |
| 81025 | <1% | 6,498 | $1K | |
| 81001 | <1% | 9,057 | $1K | |
| 90688 | <1% | 75 | $1K | |
| 82570 | <1% | 1,055 | $1K | |
| 85730 | <1% | 8,300 | $1K | |
| 88342 | <1% | 628 | $1K | |
| 86140 | <1% | 1,655 | $1K | |
| 86592 | <1% | 351 | $949.35 | |
| 86803 | <1% | 492 | $938.67 | |
| 84100 | <1% | 3,303 | $891.70 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 59 | $881.81 |
| 96127 | <1% | 171 | $845.12 | |
| 88341 | <1% | 26 | $753.22 | |
| 86762 | <1% | 916 | $712.48 | |
| 73502 | <1% | 133 | $655.58 | |
| 86787 | <1% | 779 | $621.84 | |
| 77080 | <1% | 12 | $589.59 | |
| 73130 | <1% | 198 | $570.65 | |
| 82105 | <1% | 173 | $555.07 | |
| 87210 | <1% | 1,196 | $538.35 | |
| 81003 | <1% | 4,614 | $523.33 | |
| 88307 | <1% | 92 | $481.02 | |
| 74022 | <1% | 505 | $479.53 | |
| 85651 | <1% | 602 | $468.00 | |
| 97116 | <1% | 162 | $453.42 | |
| 90658 | <1% | 28 | $452.56 | |
| 87081 | <1% | 2,450 | $442.83 | |
| 87186 | <1% | 572 | $422.21 | |
| 85007 | <1% | 917 | $403.41 | |
| 99406 | <1% | 26 | $391.54 | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 15 | $383.74 |
| 70498 | <1% | 167 | $365.14 | |
| 83615 | <1% | 497 | $346.17 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,005 | $341.78 |
| 83690 | <1% | 5,110 | $318.32 | |
| 86850 | <1% | 5,288 | $303.92 | |
| 85652 | <1% | 510 | $259.90 | |
| 82550 | <1% | 588 | $223.34 | |
| 58300 | <1% | 12 | $215.00 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 957 | $201.75 |
| 84484 | <1% | 6,881 | $193.78 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 125 | $188.60 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 918 | $158.98 |
| 84460 | <1% | 113 | $158.58 | |
| 84156 | <1% | 384 | $155.91 | |
| 83605 | <1% | 2,178 | $154.46 | |
| 82565 | <1% | 151 | $154.35 | |
| 84450 | <1% | 102 | $136.27 | |
| 87077 | <1% | 218 | $110.19 | |
| 86901 | <1% | 5,329 | $93.42 | |
| 92567 | <1% | 293 | $91.35 | |
| J3490 | Unclassified drugs | <1% | 2,697 | $89.64 |
| 82077 | <1% | 1,106 | $86.12 | |
| 80076 | <1% | 42 | $84.58 | |
| 87634 | <1% | 166 | $83.53 | |
| 85379 | <1% | 2,431 | $77.43 | |
| 84425 | <1% | 12 | $71.52 | |
| 72050 | <1% | 12 | $65.05 | |
| 72110 | <1% | 26 | $65.05 | |
| 87430 | <1% | 1,571 | $63.90 | |
| 87205 | <1% | 364 | $63.47 | |
| 72170 | <1% | 24 | $59.64 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,461 | $56.68 |
| 88304 | <1% | 430 | $55.84 | |
| 72040 | <1% | 37 | $51.99 | |
| 73080 | <1% | 13 | $51.15 | |
| 87070 | <1% | 242 | $47.38 | |
| S0077 | Injection, clindamycin phosphate, 300 mg | <1% | 15 | $46.65 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 5,794 | $44.88 |
| 87040 | <1% | 655 | $38.04 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 603 | $37.15 |
| C1729 | Catheter, drainage | <1% | 151 | $32.73 |
| 73560 | <1% | 13 | $31.59 | |
| 82043 | <1% | 12 | $29.53 | |
| 82150 | <1% | 84 | $24.85 | |
| 90715 | <1% | 202 | $20.10 | |
| 83020 | <1% | 27 | $19.72 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 414 | $18.06 |
| 84145 | <1% | 220 | $16.60 | |
| 87088 | <1% | 12 | $11.28 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 2,556 | $10.79 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,155 | $2.46 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 9,345 | $0.93 |
| J2704 | Injection, propofol, 10 mg | <1% | 1,679 | $0.27 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,285 | $0.05 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,272 | $0.05 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,637 | $0.05 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 42 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 315 | $0.00 |
| 87631 | 0% | 226 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 17 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 133 | $0.00 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0% | 584 | $0.00 |
| 87420 | 0% | 244 | $0.00 | |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | 0% | 16 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 29 | $0.00 |
| 80143 | 0% | 80 | $0.00 | |
| 99152 | 0% | 111 | $0.00 | |
| 73110 | 0% | 32 | $0.00 | |
| C1765 | Adhesion barrier | 0% | 477 | $0.00 |
| C1776 | Joint device (implantable) | 0% | 12 | $0.00 |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 0% | 39 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 91 | $0.00 |
| 93325 | 0% | 54 | $0.00 | |
| 89051 | 0% | 13 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 46 | $0.00 |
| 80179 | 0% | 13 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 28 | $0.00 |
| 96376 | 0% | 3,879 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 49 | $0.00 |
| 95886 | 0% | 754 | $0.00 | |
| C1769 | Guide wire | 0% | 251 | $0.00 |
| 89060 | 0% | 52 | $0.00 | |
| 82803 | 0% | 309 | $0.00 | |
| 99417 | Prolong home eval add 15m | 0% | 12 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 176 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 0% | 60 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 12 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 0% | 151 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 65 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 61 | $0.00 |
| 76820 | 0% | 28 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAMSCHRODER, ROBIN (EVP, CHIEF FIN & BUS DEV OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Henry Ford Health System | Detroit, MI | $334.91M |
| Henry Ford Health ST. John Hospital | Chicago, IL | $159.41M |
| Henry Ford Health Providence Hospital | Novi, MI | $72.76M |
| Henry Ford Wyandotte Hospital | Wyandotte, MI | $60.54M |
| Henry Ford Health Macomb Oakland Hospital | Warren, MI | $59.25M |
| W.A. Foote Memorial Hospital | Jackson, MI | $41.32M |
| Henry Ford Macomb Hospital Corporation | Clinton Twp, MI | $40.96M |
| Henry Ford Health Genesys Hospital | Grand Blanc, MI | $31.39M |
| Henry Ford Health Macomb Oakland Hospital | Madison Heights, MI | $24.76M |
| Henry Ford Health Rochester Hospital | Rochester, MI | $11.98M |
| Henry Ford Health River District Hospital | East China, MI | $4.59M |
| W.A. Foote Memorial Hospital | Jackson, MI | $2.11M |
| Henry Ford Health Providence Hospital | Novi, MI | $255K |
| Henry Ford Health ST. John Hospital | Detroit, MI | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.